Skip to content

Mesh vs anterior repair surgery for vaginal prolapse

Mesh vs anterior repair surgery for vaginal prolapse

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN69747860
Enrollment
250
Registered
2008-06-24
Start date
2007-12-01
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Genital prolapse Urological and Genital Diseases Female genital prolapse

Interventions

Anteror fascial repair vs anterior mesh repair

Sponsors

Benenden Hospital Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Women with symptomatic anterior vaginal wall prolapse needing surgery 2. Age: No age limits

Exclusion criteria

Exclusion criteria: 1. Contraindication to mesh repair surgery: unstable diabetes, long term high dose steroids, prosthetic heart valve, marked immunosuppression 2. Connective tissue disorders (Ehler-Danlos or Marfan's) 3. Inability to give informed consent

Design outcomes

Primary

MeasureTime frame
Anatomical recurrence rate assessed using the Pelvic Organ Prolapse Quantification (POPQ) scores, assessed immediately after surgery and then 6 weeks, 6 months, 1 and 2 years post-operation.

Secondary

MeasureTime frame
1. Operating time 2. Blood loss 3. Peri-operative complications 4. Hospital stay 5. Time to recovery to normal life 6. Long-term complications (including mesh erosion). Duration of follow-up: 24 months 7. Bladder and sexual function at 6, 12 and 24 months 8. Quality of life, assessed using the EuroQol questionnaire and the Sheffield Prolapse Symptoms Questionnaire at 6, 12 and 24 months 9. Patient satisfaction, assessed at 6, 12 and 24 months 10. Pain score, assessed daily up to 7 days post-operation

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026